Author Archives: Steve Walker

Weekly medical stock spotlight: Buy, wait or run? Leaders = Otonomy, Collegium & Sage; Laggards = Selecta & Tivity.

1.Otonomy Inc. (Nasdaq:OTIC) led advancing issues last week, rocketing 73% to $5.17. A Phase 3 clinical trial (AVERTS-2) assessing Otonomy’s Otividex in patients with Ménière’s disease, achieved its primary endpoint of the… Read more »

Gluten-Free: Healthy diet, harmful fad? Or just another boon for food companies.

The News: Celiac disease is real, but there’s little evidence to support non-celiac gluten sensitivity (NCGS), according to MedPage. A new post on Science-Based Medicine argues that the dietary fad is far… Read more »

FDA warns against unproven medical claims for marijuana. “Prohibition” didn’t work, remember?

The News: Four companies selling dozens of various marijuana-derived dietary supplements have been officially warned by the US Food and Drug Administration to stop plugging their products as cures for… Read more »

Liquid biopsy for cancer detection catching on fast. You choose: simple blood test, or invasive solid tissue sample?

The News: Until recently, cancer detection depended on invasive solid tissue sampling that didn’t provide a complete picture. Now, a budding cluster biotechs is making it easier to detect cancer… Read more »

John McCain in Phase 1 trial of Bexion’s solid cancer tumor candidate; Bexion who?

The News: In late September, the University of New Mexico Comprehensive Cancer Center (UNMCC) announced that the first clinical trials of a new drug that targets solid cancer tumors have… Read more »

Fancy this: Pharma gifts to docs still paying off–big time.

The News: Giving someone a box of donuts may seem like a harmless gesture, but for pharmaceutical companies it could boost sales. A new study of healthcare providers in the… Read more »

What’s wrong with Celgene as shares get clobbered? Nothing, actually.

The News: Celgene Corp. (Summit NJ) plummeted 20% Thursday (October 26, 2017) to $99.99 after releasing third-quarter earnings. And it wasn’t so much third-quarter revenue, which was up 10% year over year,… Read more »

Breakthrough study says blood thinners cut dementia risk by half. Message: If you start taking them, don’t quit.

The News: Anticoagulant drugs may protect against dementia as well as stroke in people with an irregular heartbeat, new research suggests. A Swedish study found that patients being treated for… Read more »

McConnell willing to hold Senate vote on bipartisan health deal if Trump endorses, but what are the odds of passage?

The News: Senator Mitch McConnell of Kentucky, the majority leader, said on Sunday (October 22, 2017) that he would be willing to bring a bipartisan proposal to stabilize health insurance… Read more »